BioXcel Therapeutics BTAI
$ 0.34
8.12%
Quarterly report 2024-Q3
added 11-14-2024
BioXcel Therapeutics Cash Flow 2011-2024 | BTAI
Annual Cash Flow BioXcel Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-155 M | -135 M | -82.2 M | -66.4 M | -27.1 M | -13.5 M | -2.2 M | - | - | - | - | - | - |
Depreciation & Amortization |
318 K | 327 K | 297 K | 188 K | 156 K | 17 K | 1 K | - | - | - | - | - | - |
Accounts Payables |
13.7 M | 10.2 M | 4.68 M | 3.98 M | 4.95 M | 1.6 M | - | - | - | - | - | - | - |
Accounts Receivables |
71 K | 248 K | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
1.99 M | 1.98 M | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow BioXcel Therapeutics
2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | - | - | - | - | - | -96.7 M | -65.5 M | -32.4 M | - | -62.2 M | -42 M | -19.6 M | - | -46.1 M | -27 M | -12.2 M | - | -19.2 M | -11.7 M | -5.67 M | - | -9.17 M | -5.98 M | -1.01 M | - | -1.1 M | -776 K | -431 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
77 K | 77 K | - | 79 K | 81 K | - | - | 85 K | 84 K | 77 K | - | 76 K | 80 K | 65 K | - | 47 K | 47 K | 47 K | - | 218 K | 122 K | 37 K | - | 9 K | 2 K | - | - | 1 K | - | 1 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
14.9 M | 13.3 M | 13.7 M | 10.7 M | 11.2 M | - | 10.2 M | 5.87 M | 6.02 M | 5.06 M | 4.68 M | 3.44 M | 2.5 M | 5.31 M | 3.98 M | 3.98 M | 3.98 M | 3.98 M | 4.95 M | 4.95 M | 4.95 M | 4.95 M | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 444 K | 444 K | 444 K | 444 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
3 K | 812 K | 71 K | 735 K | 431 K | - | 248 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
1.52 M | 2.68 M | 1.99 M | 2.02 M | 1.92 M | - | 1.98 M | 1.41 M | 1.4 M | 682 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency